PMID- 34007653
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220423
IS  - 2155-0417 (Electronic)
IS  - 2155-0417 (Linking)
VI  - 11
IP  - 4
DP  - 2020
TI  - Continuous Glucose Monitoring for Underserved and Minority Patients with Type 2 
      Diabetes in an Interprofessional Internal Medicine Clinic.
LID - 10.24926/iip.v11i4.3501 [doi]
AB  - OBJECTIVE: Evaluate the impact of interprofessional continuous glucose monitoring 
      (CGM) on glycemic control in underserved and minority patients with type 2 
      diabetes mellitus (T2DM). METHODS: The IRB-approved, retrospective 
      quasi-experimental study was conducted between August 2018 and August 2019 at an 
      internal medicine residency clinic. Adult patients with diagnosed T2DM, an 
      indication for CGM (hyperglycemia, hypoglycemia, and/or glycemic variability), 
      and at least 10 consecutive days of CGM data were included. Patients who were 
      pregnant and/or missed one or more clinic appointments were excluded. Patients 
      were followed weekly over a 14-day period during which data from the CGM sensor 
      were downloaded and interpreted by the interprofessional team. Interventions with 
      shared decision-making were made at each visit. RESULTS: Fifty-five patients were 
      included, with a mean age of 61+11.2 years, 86% were of non-white race, and 56% 
      were female. Average blood glucose levels decreased from 208.39 mg/dL at week 1 
      to 190.74 mg/dL at week 2, a 17.65 mg/dLreduction (p = 0.0281). Time within 
      target range (70-180 mg/dL) increased by 6.16% (p = 0.0038), while time above 
      range (>180 mg/dL) decreased by 5.5% (p = 0.0168). Average number of hypoglycemic 
      events (readings <70 mg/dL) did not change significantly from week 1 to week 2 
      (2.94 vs. 3.64, p > 0.05). Of the 66 interventions made after week 1, 33% were 
      made by the pharmacy team, 56% were made by the attending or resident physicians, 
      and 11% were made by the dietician. Of 59 interventions made after week 2, 32% 
      were made by the pharmacy team, 49% were made by the attending or resident 
      physicians, and 19% were made by the dietician. CONCLUSIONS: The 
      interprofessional collaborative CGM service was associated with improvements in 
      glucose control based on increased time within target range and reduced 
      hyperglycemia, without increasing the risk of hypoglycemia or medication burden.
CI  - (c) Individual authors.
FAU - Bui, Arden
AU  - Bui A
AD  - University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC.
FAU - Kim, Jennifer
AU  - Kim J
AD  - University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC.
AD  - Moses Cone Internal Medicine Clinic, Cone Health, Greensboro, NC.
LA  - eng
PT  - Journal Article
DEP - 20201203
PL  - United States
TA  - Innov Pharm
JT  - Innovations in pharmacy
JID - 101574764
PMC - PMC8127115
OTO - NOTNLM
OT  - Interprofessional
OT  - continuous glucose monitoring
OT  - diabetes
OT  - pharmacy education
COIS- Conflicts of interest: none
EDAT- 2021/05/20 06:00
MHDA- 2021/05/20 06:01
PMCR- 2020/12/03
CRDT- 2021/05/19 06:50
PHST- 2021/05/19 06:50 [entrez]
PHST- 2021/05/20 06:00 [pubmed]
PHST- 2021/05/20 06:01 [medline]
PHST- 2020/12/03 00:00 [pmc-release]
AID - 10.24926/iip.v11i4.3501 [doi]
PST - epublish
SO  - Innov Pharm. 2020 Dec 3;11(4):10.24926/iip.v11i4.3501. doi: 
      10.24926/iip.v11i4.3501. eCollection 2020.